Braunschweig, Germany

Lutz Fischer

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lutz Fischer. Retrieved from https://idiyas.com/inventor/lutz-fischer-48eazwvf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lutz Fischer: Innovator in Enantiomer Separation

Introduction

Lutz Fischer is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of chemistry, particularly in the separation of enantiomers. His work has implications for various applications in pharmaceuticals and chemical synthesis.

Latest Patents

Lutz Fischer holds a patent for a "Method for separating enantiomers of aryloxipropanolamine derivatives." This innovative method addresses the challenges associated with the separation of chiral compounds, which is crucial for the development of effective medications.

Career Highlights

Throughout his career, Lutz Fischer has demonstrated a commitment to advancing chemical processes. His patent reflects his expertise and dedication to improving methods in the field. With a total of 1 patent, he has established himself as a valuable contributor to scientific research.

Collaborations

Lutz Fischer has collaborated with esteemed colleagues, including Ralf Muller and Klaus Mosbach. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Lutz Fischer's contributions to the field of chemistry, particularly through his patented method for enantiomer separation, highlight his role as an influential inventor. His work continues to impact the scientific community and the development of new pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…